7543 Methylglyoxal synthase-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic nitrogen compounds | 1 | 0.3 | 3.97× | not tested | |
| Homogeneous non-metal compounds | 4 | 1.7 | 2.36× | not tested | |
| Organic acids and derivatives | 2 | 1.2 | 1.64× | not tested | |
| Nucleosides, nucleotides, and analogues | 3 | 2.2 | 1.38× | not tested | |
| Organic oxygen compounds | 2 | 1.6 | 1.27× | not tested | |
| Organoheterocyclic compounds | 1 | 1.2 | 0.82× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08837 | NET | Tetraethylammonium | 36 |
| DB00129 | ORN | Ornithine | 33 |
| DB02726 | PGA | 2-Phosphoglycolic Acid | 18 |
| DB02309 | XMP | 5-monophosphate-9-beta-D-ribofuranosyl xanthine | 12 |
| DB01700 | AMZ | AICA ribonucleotide | 6 |
| DB03026 | PGH | Phosphoglycolohydroxamic Acid | 6 |
| DB03685 | U5P | Uridine monophosphate | 4 |
| DB04566 | IMP | Inosinic Acid | 4 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB00116 | — | — | 1 |
| DB00563 | — | Methotrexate | 1 |
| DB00642 | — | Pemetrexed | 1 |
| DB03442 | — | Acid yellow 54 free acid | 1 |
| DB04057 | — | N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid | 1 |
| DB06775 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ORN | L-ornithine | 40 |
| NET | TETRAETHYLAMMONIUM ION | 35 |
| CL | CHLORIDE ION | 18 |
| PGA | 2-PHOSPHOGLYCOLIC ACID | 18 |
| XMP | XANTHOSINE-5'-MONOPHOSPHATE | 8 |
| AMZ | AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE | 6 |
| PGH | PHOSPHOGLYCOLOHYDROXAMIC ACID | 6 |
| GLN | GLUTAMINE | 4 |
| IMP | INOSINIC ACID | 4 |
| BR | BROMIDE ION | 3 |
| JLN | 5-(FORMYLAMINO)-1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID | 3 |
| 13A | 7-(3,4-DIHYDROXY-5R-HYDROXYMETHYLTETRAHYDROFURAN-2-YL)-2,2-DIOXO-1,2R,3R,7-TETRAHYDRO-2L6-IMIDAZO[4,5-C][1,2,6]THIADIAZIN-4S-ONE | 2 |
| 203 | 1,5-DIHYDROIMIDAZO[4,5-C][1,2,6]THIADIAZIN-4(3H)-ONE 2,2-DIOXIDE | 2 |
| 93A | [3,4-DIHYDROXY-5R-(2,2,4-TRIOXO-1,2R,3S,4R-TETRAHYDRO-2L6-IMIDAZO[4,5-C][1,2,6]THIADIAZIN-7-YL)TETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE | 2 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 1 |